At the news
? NEUTRALIMPACT 3/10 144 filed May 15, 2026 at 16:10 ET
Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 on May 15, 2026, indicating intent to sell 10,000 shares of common stock with an approximate market value of $632,543. The shares were acquired via stock option exercise on the same day. This is a routine insider sale following option exercise, not a material signal of deteriorating fundamentals.
- Insider Dennis Mulroy (Officer) filed Form 144 to sell 10,000 shares
- Estimated sale value: ~$632,543 based on filing date market price
- Shares acquired via stock option exercise on May 15, 2026
- Sale represents a modest portion of total holdings (relative to 29,100,902 shares outstanding)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access